Literature DB >> 3729404

Plasmid carriage in Vibrio vulnificus and other lactose-fermenting marine vibrios.

L S Davidson, J D Oliver.   

Abstract

A total of 42 clinical and environmental isolates of Vibrio vulnificus were examined for plasmid carriage. Of these, only five (12%) harbored plasmids, which were of various molecular weights. In contrast, 20 of 32 (62.5%) unidentified lactose-fermenting Vibrio spp. were found to possess plasmids with masses of 2.1 to 150 megadaltons. In these isolates, multiple plasmids were common, with an average of 2.25 plasmids per plasmid-containing strain. Attempts to demonstrate a correlation with the plasmids identified in the various Vibrio spp. and a variety of phenotypic traits, production of several enzymes potentially involved in virulence, cytotoxicity for Chinese hamster ovary cells, and mouse lethality were unsuccessful. A correlation was observed, however, between the presence of a 6.5-megadalton plasmid and resistance to pteridine 0/129. It was concluded that V. vulnificus, unlike most other Vibrio spp., shows a general lack of these extrachromosomal elements.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729404      PMCID: PMC203455          DOI: 10.1128/aem.52.1.211-213.1986

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  20 in total

1.  Incidence of Plasmids in Marine Vibrio spp. Isolated from an Oil Field in the Northwestern Gulf of Mexico.

Authors:  H S Hada; R K Sizemore
Journal:  Appl Environ Microbiol       Date:  1981-01       Impact factor: 4.792

2.  Serology and plasmid carriage in Vibrio cholerae.

Authors:  J W Newland; M J Voll; L A McNicol
Journal:  Can J Microbiol       Date:  1984-09       Impact factor: 2.419

3.  A rapid boiling method for the preparation of bacterial plasmids.

Authors:  D S Holmes; M Quigley
Journal:  Anal Biochem       Date:  1981-06       Impact factor: 3.365

4.  Isolation of cryptic plasmid deoxyribonucleic acid from Kanagawa-positive strains of Vibrio parahaemolyticus.

Authors:  P Guerry; R R Colwell
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Necrotizing soft-tissue infections caused by marine vibrios.

Authors:  R J Howard; M E Pessa; B H Brennaman; R Ramphal
Journal:  Surgery       Date:  1985-07       Impact factor: 3.982

6.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

7.  Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus.

Authors:  A C Wright; J G Morris; D R Maneval; K Richardson; J B Kaper
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Distribution and ecology of Vibrio vulnificus and other lactose-fermenting marine vibrios in coastal waters of the southeastern United States.

Authors:  J D Oliver; R A Warner; D R Cleland
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

9.  Siderophore production by Vibrio vulnificus.

Authors:  L M Simpson; J D Oliver
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

10.  Role of iron in the pathogenesis of Vibrio vulnificus infections.

Authors:  A C Wright; L M Simpson; J D Oliver
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

View more
  19 in total

1.  Complete sequence of plasmid pMP1 from the marine environmental Vibrio vulnificus and location of its replication origin.

Authors:  Ruifu Zhang; Ji-Dong Gu
Journal:  Mar Biotechnol (NY)       Date:  2008-11-14       Impact factor: 3.619

2.  Correlation between virulence and colony morphology in Vibrio vulnificus.

Authors:  L M Simpson; V K White; S F Zane; J D Oliver
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Bioluminescence in a strain of the human pathogenic bacterium Vibrio vulnificus.

Authors:  J D Oliver; D M Roberts; V K White; M A Dry; L M Simpson
Journal:  Appl Environ Microbiol       Date:  1986-11       Impact factor: 4.792

4.  Comparison of ribotyping and randomly amplified polymorphic DNA PCR for characterization of Vibrio vulnificus.

Authors:  L Høi; A Dalsgaard; J L Larsen; J M Warner; J D Oliver
Journal:  Appl Environ Microbiol       Date:  1997-05       Impact factor: 4.792

5.  Antibiotic resistance of Vibrio anguillarum, in relation to serovar and plasmid contents.

Authors:  K Pedersen; T Tiainen; J L Larsen
Journal:  Acta Vet Scand       Date:  1995       Impact factor: 1.695

6.  Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark.

Authors:  A Dalsgaard; N Frimodt-Møller; B Bruun; L Høi; J L Larsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

7.  Genetic relatedness among environmental, clinical, and diseased-eel Vibrio vulnificus isolates from different geographic regions by ribotyping and randomly amplified polymorphic DNA PCR.

Authors:  C R Arias; M J Pujalte; E Garay; R Aznar
Journal:  Appl Environ Microbiol       Date:  1998-09       Impact factor: 4.792

8.  Analysis of Vibrio vulnificus from market oysters and septicemia cases for virulence markers.

Authors:  Angelo DePaola; Jessica L Nordstrom; Anders Dalsgaard; Anita Forslund; James Oliver; Tonya Bates; Keri L Bourdage; Paul A Gulig
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

9.  Characterization of Vibrio fluvialis-like strains implicated in limp lobster disease.

Authors:  B D Tall; S Fall; M R Pereira; M Ramos-Valle; S K Curtis; M H Kothary; D M T Chu; S R Monday; L Kornegay; T Donkar; D Prince; R L Thunberg; K A Shangraw; D E Hanes; F M Khambaty; K A Lampel; J W Bier; R C Bayer
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

10.  Presence of a capsule in Vibrio vulnificus biotype 2 and its relationship to virulence for eels.

Authors:  E G Biosca; H Llorens; E Garay; C Amaro
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.